Department of Integrative Biology and Pharmacology, McGovern Medical School, Graduate Program in Cell and Regulatory Biology, the University of Texas Health Science Center at Houston, Houston, Tex; Center for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, Tex.
Center for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, Tex; Xiangya Hospital, Xiangya School of Medicine, Central South University, Changsha, China.
J Allergy Clin Immunol. 2018 Oct;142(4):1311-1321.e8. doi: 10.1016/j.jaci.2018.02.050. Epub 2018 Apr 18.
The inhibitory receptor programmed cell death protein 1 (PD-1) is upregulated on a variety of immune cells, including natural killer (NK) cells, during chronic viral infection and tumorigenesis. Blockade of PD-1 or its ligands produces durable clinical responses with tolerable side effects in patients with a broad spectrum of cancers. However, the underlying molecular mechanisms of how PD-1 regulates NK cell function remain poorly characterized.
We sought to determine the effect of PD-1 signaling on NK cells.
PD-1 was overexpressed in CD16-KHYG-1 (a human NK cell line with both antibody-dependent cellular cytotoxicity through CD16 and natural cytotoxicity through NKG2D) cells and stimulated by exposing the cells to NK-sensitive target cells expressing programmed death ligand 1 (PD-L1).
PD-1 engagement by PD-L1 specifically blocked NK cell-mediated cytotoxicity without interfering with the conjugation between NK cells and target cells. Further examination showed that PD-1 signaling blocked lytic granule polarization in NK cells, which was accompanied by failure of integrin-linked kinase, a key molecule in the integrin outside-in signaling pathway, to accumulate in the immunological synapse after NK-target cell conjugation.
Our results suggest that NK cell cytotoxicity is inhibited by PD-1 engagement, which blocks lytic granule polarization to the NK cell immunological synapse with concomitant impairment of integrin outside-in signaling. This study provides novel mechanistic insights into how PD-1 inhibition disrupts NK cell function.
在慢性病毒感染和肿瘤发生过程中,多种免疫细胞(包括自然杀伤(NK)细胞)表面程序性细胞死亡蛋白 1(PD-1)抑制性受体上调。阻断 PD-1 或其配体在具有广泛癌症谱的患者中产生持久的临床反应,且副作用可耐受。然而,PD-1 如何调节 NK 细胞功能的潜在分子机制仍知之甚少。
我们旨在确定 PD-1 信号对 NK 细胞的影响。
在 CD16-KHYG-1(一种具有通过 CD16 的抗体依赖性细胞细胞毒性和通过 NKG2D 的自然细胞毒性的人 NK 细胞系)细胞中过表达 PD-1,并通过使细胞暴露于表达程序性死亡配体 1(PD-L1)的 NK 敏感靶细胞来刺激 PD-1 信号。
PD-L1 与 PD-1 的结合特异性阻断 NK 细胞介导的细胞毒性,而不干扰 NK 细胞与靶细胞之间的连接。进一步的研究表明,PD-1 信号阻断了 NK 细胞中的溶酶体颗粒极化,这伴随着整合素连接激酶(整合素外侧信号通路中的关键分子)在 NK-靶细胞连接后不能在免疫突触中积累。
我们的研究结果表明,PD-1 结合抑制 NK 细胞毒性,该抑制作用通过阻止 NK 细胞免疫突触中的溶酶体颗粒极化,同时损害整合素外侧信号通路。这项研究为 PD-1 抑制如何破坏 NK 细胞功能提供了新的机制见解。